ISRCTN57305201已完成未知
Clostridium difficile - adjuvant therapy with high dose VSL#3® will shorten hospital stay and reduce relapse rates in Clostridium difficile associated diarrhoea: a multicentre double blind randomised placebo controlled trial
niversity Hospitals Bristol NHS Foundation Trust (UK)0 个研究点目标入组 114 人开始时间: 2008年2月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 114
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Any consenting adult patient over the age of 18 years admitted to a Clostridium difficile Cohort Ward in either Gloucester Royal Hospital or Cheltenham General Hospital. Male and female genders will be included.
排除标准
- •There is no upper age limit and patients with IBD will not be excluded. Apart from this, the following patients will be excluded:
- •1. Those with evidence of dilated colon on plain abdominal film on admission
- •2. Any patient known to be immunosuppressed (including those on steroids)
- •3. Any patient refusing the VSL#3® as part of their treatment regime
- •4. Patients with lactose intolerance or allergy
- •5. Any patient with a history of rheumatic heart disease or prosthetic heart valve
- •6. Any patient with a history of endocarditis
研究者
相似试验
尚未招募
3 期
Treatment of recurrent Clostridium difficile infection with fecal therapy: the FECAL trial (Fecal enema to Eliminate Clostridium difficile Associated Longstanding diarrhea)bacterial infectionschronic diarrhea1001796610004018NL-OMON30253Academisch Medisch Centrum136
尚未招募
不适用
A prospective study of Clostridium difficile infection and quality improvement initiative based on automatic CVRCertain infectious and parasitic diseasesKCT0005892The Catholic University of Korea, Bucheon St. Mary's Hospital200
招募中
不适用
Clinical aspects of Clostridium difficile infection after initiation of anti tuberculous medicatioCertain infectious and parasitic diseasesKCT0000808Konyang University Hospital50
招募中
不适用
The FECAL trial, Fecal therapy to Eliminate Clostridium difficile Associated Longstanding diarrhoea.1. Clostridium difficile<br />2. Recurrent (NLD: recidiverend)<br />3. antibiotic associated diarrhoea<br />4. diarrhoea (NLD: diarree)<br />5. feces (NLD: ontlasting)<br />6. transplantation (NLD: transplantatie).NL-OMON25892Academic Medical Center Amsterdamthe Netherlands120
进行中（未招募）
1 期
VANCALLO - Prevention of C. difficile infections by oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a randomized double-blind placebo-controlled trialPatients hospitalized for allogeneic hematopoietic stem cell transplantationMedDRA version: 20.0Level: PTClassification code: 10054236Term: Clostridium difficile infection Class: 100000004862CTIS2024-513490-45-00Assistance Publique Hopitaux De Paris336